Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_66876
http://purl.obolibrary.org/obo/CHEBI_66876
|
|---|---|
| Preferred Name | avanafil |
| Synonyms |
4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Stendra
(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
avanafil
C23H26ClN7O3
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | avanafil
|
|---|---|
| label | avanafil
|
| DBSynonym | ta-1790
|
| Definition | Avanafil is a new phosphodiesterase-5 inhibitor that is faster acting and more selective than other drugs belonging to the same class. Chemically, it is a derivative of pyrimidine and is only available as the S-enantiomer. FDA approved on April 27, 2012.
A carboxamide obtained by formal condensation of the carboxy group of 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid with the amino group of pyrimidin-2-ylmethylamine. Used for treatment of erectile dysfunction.
|
| has pharmacological target | |
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=WEAJZXNPAWBCOA-INIZCTEOSA-N
|
| is metabolised by | |
| AHFScode | 24:12.12
|
| Synonym | 4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Stendra
(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
avanafil
C23H26ClN7O3
See more
See less
|
| xref |
Wikipedia:Avanafil
CiteXplore:22704456
CiteXplore:20939743
CiteXplore:18197727
Drugs.com:http://www.drugs.com/mtm/avanafil.html
CiteXplore:22248153
CiteXplore:18491987
Patent:US6403597
KEGG DRUG:D03217
CiteXplore:22448738
CiteXplore:22759639
National Drug Code Directory:62541-303-30
ChEMBL:1385392
Patent:EP1366760
CASRN:330784-47-9
CiteXplore:21745238
CiteXplore:22788525
CiteXplore:22384456
ChEBI:66876
RxList:http://www.rxlist.com/stendra-drug.htm
CiteXplore:22087063
Reaxys:11746013
CiteXplore:21905762
CiteXplore:20637970
Wikipedia:http://en.wikipedia.org/wiki/Avanafil
See more
See less
|
| CASRN | 330784-47-9
|
| prefixIRI | obo2:CHEBI_66876
|
| SMILES |
COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl
COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1
|
| DBBrand | stendra
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |